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Autophagy is a survival pathway wherein non-functional proteins and organelles 
are degraded in lysosomes for recycling and energy production. Therefore, 
autophagy is fundamental for the maintenance of cell viability, acting as a 
quality control process that prevents the accumulation of unnecessary structures 
and oxidative stress. Increasing evidence has shown that autophagy dysfunction 
is related to several pathologies including neurodegenerative diseases and cancer. 
Moreover, recent studies have shown that autophagy plays an important role 
for the maintenance of bone homeostasis. For instance, in vitro and animal 
and human studies indicate that autophagy dysfunction in bone cells is 
associated with the onset of bone diseases such as osteoporosis. This review 
had the purpose of discussing the issue to confirm whether a relationship 
between autophagy dysfunction and osteoporosis exits.
Keywords: autophagy, bone tissue, osteoblast, osteocyte, osteoclast, osteoporosis.
introduction
Bone tissue is constantly being remodeled by the coordi-
nated action of osteoclasts, osteoblasts, osteocytes, and 
bone lining cells.1,2 Osteoclasts and osteoblasts are respec-
tively responsible for bone resorption and formation, while 
osteocytes are important in maintaining and controlling 
bone remodeling.2-5 Bone remodeling is necessary for the 
repair of microfractures, as well as for skeletal adaptation 
to different mechanical stimuli and for calcium homeo-
stasis.6 However, any imbalance in this process so that bone 
reabsorption exceeds formation can result in bone loss and 
subsequent osteoporosis.7-10
Osteoporosis is a systemic bone disease characterized 
by progressive loss of bone mass, bone fragility and sus-
ceptibility to fractures.11 The incidence of osteoporotic 
fractures, associated with morbidity, mortality and the 
costs of these fractures, has increased substantially and 
became a public health problem in many countries,12-14 
including Brazil.15-17 As life expectancy increases, the num-
ber of osteoporotic fractures is expected to increase from 
1.7 million in 1990 to 6.3 million in 2050.18
The cause of osteoporosis is multifactorial and in-
cludes genetic, hormonal and nutritional factors, com-
bined with people’s lifestyle choices.19,20 Peak bone mass 
is reached early in adult life and from this point both men 
and women start to lose bone mass more or less depend-
ing on a combination of intrinsic and extrinsic factors.21,22 
This process can be aggravated by a lack of physical exer-
cise,23 prolonged treatment with corticoids,24 estrogen 
deficiency, especially in postmenopausal women,25 pres-
ence of other chronic diseases, and by aging.20
Recent evidence has pointed out that autophagy, a 
cell survival pathway, plays an important role in the main-
tenance of bone homeostasis,26-28 and changes in this 
pathway have been related to osteoporosis.29,30 Since os-
teoporosis became a serious public health problem with 
an incidence rate that is likely to increase in the next de-
cades, understanding the cellular and molecular mecha-
nisms involved in the process of bone loss is crucial and 
paramount for the development of new therapies.
In this review, we discuss studies that associate the 
autophagic pathway with osteoporosis, aiming to better 
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understand if there is a possible correlation between these 
two processes.
autophagy
Autophagy (from the Greek autos, self, and phagein, eat) is 
a lysosomal degradation pathway responsible for the 
degradation and recycling of cellular components such 
as unnecessary organelles and proteins, also serving to 
destroy intracellular pathogens.31-33 Autophagy occurs in 
every cell so that structures that are unnecessary to the 
cell can be recycled. However, factors that induce cellular 
stress, such as hypoxia, caloric restriction and the accu-
mulation of oxidative stress, can induce autophagy.34-36
Three types of autophagy are described: macroau-
tophagy, microautophagy and chaperone-mediated au-
tophagy. The latter involves direct translocation of cyto-
plasmic proteins into lysosomes, aided and directed by 
chaperone proteins.37 In microautophagy, invagination of 
the lysosomal membrane results in small portions of the 
cytoplasm being captured towards the lysosome lumen.38,39 
Macroautophagy, hereafter referred to as autophagy, is 
the most studied of the three autophagic pathways, it has 
been maintained throughout evolution, from yeast to 
mammals, and is characterized by the formation of au-
tophagosomes.40,41 After autophagic stimulation, a small 
vesicle called the phagophore elongates and subsequently 
surrounds a portion of the cytoplasm, resulting in the 
formation of a double membrane structure, termed au-
tophagosome.31,42 The membrane of the autophagosome 
then fuses with a lysosome, resulting in the degradation 
of the entrapped material. Amino acids, fatty acids and 
other molecules resulting from degradation return to the 
cytoplasm for recycling and energy production.38,42
Usually, the autophagic process is divided into four 
main steps: initiation/nucleation, elongation, maturation 
and degradation.38,42 During initiation, which takes place 
after autophagic stimulus, a membrane known as phag-
ophore is formed. Phagophore formation and nucleation 
occur with the formation of two multiprotein complexes: 
one is composed of proteins ULK1/2, Atg13 and FIP200, 
and the other, which is known as class III phosphati-
dylinositol 3-kinase (PI3K) complex, is formed by proteins 
beclin-1, Vps15, Vps34, Ambra1, UVRAG, and more.33,43 
These complexes, with the participation of several other 
proteins, are responsible for recruiting and initiating 
phagophore elongation.44  Beclin-1 is fundamental for 
the formation of PI3K complexes and, therefore, has been 
commonly used as a marker of autophagia.45
After nucleation, phagophore elongation occurs and 
an autophagosome is formed. This process is coordi-
nated by two protein complexes called ubiquitin-like 
conjugation system, formed by several Atgs (autophagy-
-related genes) proteins, including Atg3, Atg4, Atg5, Atg7, 
Atg10, Atg12 and Atg16. This system facilitates conjuga-
tion of a molecule called LC3 (a light chain of the micro-
tubule-associated protein 1) with phospholipid phospha-
tidylethanolamine to LC3II. LC3II then enters the 
autophagosome’s membrane, assisting its elongation and 
closure.38,46 Therefore, it is currently known that LC3II is 
found within the autophagosome’s membrane, being key 
to its formation. Because of that, LC3II has been widely 
used as a specific autophagosome marker.38,47 
The other stages of autophagy consist in autophago-
some maturation and degradation of its contents. Au-
tophagosome maturation refers to its fusion with com-
ponents of the endocytic pathway, such as early and late 
endosomes and lysosomes, turning the contents inside 
the autophagosome acid.48 Several proteins involved in 
vesicular transport, such as dynein, and membrane fusion 
in the endocytic pathway, including Rab7, SNARES and 
ESCRT, beclin-1, Vps34 and UVRAG, are involved in au-
tophagosome maturation.49 The last stage of the autoph-
agic pathway is that of degradation of the autophago-
some’s contents after fusing with a lysosome and 
subsequent reuse of the resulting molecules (lipids, ami-
no acids, nucleotides, etc.) as a manner of recycling cell 
components and producing energy.50
For a long time, autophagy was considered a pathway 
of non-selective degradation.48 However, it is currently 
accepted that this process can be extremely specific since 
organelles are selectively targeted for degradation.51 The 
most widely known example of protein-specific autoph-
agic degradation is that of protein p62 (ou SQSTM1), 
which binds to ubiquitinated proteins leading them to 
the interior of autophagosomes.52 This mechanism is 
mediated by binding of p62 to LC3II present in the au-
tophagosome’s membrane, so that p62 is also internalized 
and ultimately degraded. This protein is thus considered 
as one of the main substrates for autophagosomes and, 
therefore, its increased expression indicates decline in 
the autophagic process and vice versa. Analyses of the 
combined expression of proteins p62 and LC3II are com-
monly used to assess the autophagic flow in cells.53,54 A 
summary of the major stages of the autophagic pathway 
is illustrated in Figure 1.
role of autophagy in Bone Biology
In recent years, a growing number of studies has shown 
that autophagy plays an important role to maintain bone 
homeostasis.26,27,55 For example, cultures of autophagy 
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gene-knockout osteoblasts (BECN-1, ATG7 e LC3) result 
in deficiency in the process of mineralization.56
In vitro studies show that pharmacological inhibition 
of autophagy in osteoblast-like cells increases oxidative 
stress and stimulates apoptosis in these cells. In contrast, 
induction of autophagy in cultures of osteoblast-like cells 
reduces their oxidative stress and inhibits apoptosis.57 It 
has also been reported that estrogen inhibits osteoblast 
apoptosis in vitro, inducing autophagy in these cells.58
Autophagy is also essential when osteoblasts are in-
corporated into the bone matrix, thus becoming osteo-
cytes.59 During the transition, osteoblasts undergo evident 
changes in their shape, accompanied by a significant re-
duction in the number and size of organelles.60 It is as-
sumed that an increase in the autophagic process occurs 
during this transition from osteoblasts to osteocytes. This 
increase is due to the need for faster organelle recycling 
and preservation of nutrients, while the cell develops its 
actin-rich prolongations, and adjusts to an environment 
more susceptible to hypoxia.59 In fact, the expression of 
LC3 in osteocytes is greater than in osteoblasts.61
Osteocytes are long-lived cells located in gaps delim-
ited by mineralized bone matrix and, consequently, are 
positioned in an environment more susceptible to hypox-
ia and to the accumulation of oxidative stress.55 It is believed 
that under these conditions autophagy plays an important 
role in the survival of osteocytes.59 Osteocyte-like cells have 
increased autophagic activity after undergoing nutrient 
deprivation and hypoxia in vitro, conditions that are sim-
ilar to those found in osteocytes in vivo. In addition, in 
FIGURE 1 Schematic model of the four main stages of the autophagic pathway: 1. initiation/nucleation; 2. elongation; 3. maturation; and 4. 
degradation. After autophagic stimulation (oxidative stress, hypoxia, lack of nutrients, etc.), phagosome formation/nucleation is observed (1), 
assisted by multiprotein complexes PI3K (formed by beclin-1, Vps34/15, Ambra-1 and UVRAG) and ULK1/ULK2, as well as Atgs. Assisted by 
protein LC3II, the phagophore elongates and circles organelles and proteins that are no longer functional (2), including polyubiquitinated 
proteins (PU) carried by p62, forming the autophagosome. The latter may fuse with a lysosome (3), so that its contents are degraded (4). 
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response to calcium-mediated stress, a hypoxia-inducing 
transcription factor (HIF-1) positively regulates autopha-
gy, indicating that low oxygen tension serves as a regulator 
of autophagy in this type of cell.61 Low-dose glucocorticoid 
treatment has also been shown to induce autophagy in 
osteocytes in response to increased oxidative stress caused 
by treatment, preserving the viability of these cells.62-64
Studies indicate that autophagy also plays an important 
role in bone resorption by osteoclasts.65 It has been re-
ported that proteins involved in the autophagic pathway 
are important in the regulation of osteoclastogenesis,66,67 
indicating that this process participates both in bone for-
mation and resorption. There is evidence that resorptive 
activity is decreased when bafilomycin, an autophagy in-
hibitor, is added to the culture of osteoclasts.68,69 In mice, 
a mutation in the gene encoding the p62 protein has also 
been reported to result in a phenotype similar to Paget’s 
bone disease, a condition in which there is excessive increase 
in bone remodeling and susceptibility to fractures.70 In 
addition, it has been reported that an increase in autoph-
agy occurs during osteoclastogenesis under conditions of 
hypoxia and increased oxidative stress caused by glucocor-
ticoid treatment. In this case, it was suggested that au-
tophagy would act as a protective factor reducing cell stress, 
increasing the formation and viability of osteoclasts.71-73   
Deletions in genes encoding key proteins in the for-
mation of the autophagosome (ATG5, ATG7, ATG4B and 
LC3) have been shown to cause changes in the brush 
border formation of osteoclasts, and, consequently, to 
reduce bone resorption and increase bone volume, thus 
preventing bone loss in mice after ovariectomy.65 Some 
authors suggest that inhibition of autophagy in osteoclasts 
may serve as a possible therapeutic mechanism against 
bone diseases in which there is an excessive increase in 
bone resorption.55,72 In fact, it has recently been observed 
in mice that pharmacological and genetic inhibition of 
autophagy reduces osteoclastogenesis and bone resorp-
tion, inhibiting bone loss caused by ovariectomy or glu-
cocorticoid treatment.74
Recently, autophagy has also been pointed as an im-
portant factor in the process of bone growth. It was ob-
served that the secretion of type II collagen by chondro-
cytes of the epiphyseal disc of mice is regulated by 
autophagy, under the influence of fibroblast growth fac-
tor 18  (FGF18).28 However, the mechanisms by which 
autophagy regulates the secretion of type II collagen dur-
ing bone growth are still not fully understood. A clinical 
trial of gene screening that included 618 adult Chinese 
subjects demonstrated that the expression of genes regu-
lating the autophagic pathway may influence stature 
variation in this population.75 Considering that autoph-
agy increases the viability of chondrocytes, the authors 
report that this influence can be attributed to the protec-
tive role that autophagy exerts on these cells in the epiph-
yseal disc, thus influencing the growth of long bones.76
Other recent studies indicate that the activation of 
autophagy is also associated with the repair process of 
bone fractures.77,78 In this case, it has been proposed that 
the increase in autophagy that occurs after a bone injury 
would act as a defense mechanism of the bone cells against 
cell stress, caused by the sudden reduction or interruption 
of the nutrient supply, due to bone fracture.78 Thus, stud-
ies indicate that autophagy is a crucial factor for the 
maintenance of bone tissue homeostasis.
autophagy, Bone loss and osteoporosis: 
What is the evidence?
It has been widely reported that dysfunction in the au-
tophagic pathway is involved in the development of var-
ious pathologies such as: neurodegenerative (e.g. Alzheim-
er’s and Parkinson’s)79 and vascular80 diseases, cancer,81 
diabetes,82 obesity,83 rheumatoid arthritis,84 and osteoar-
thritis.85 Studies suggest that dysregulation of autophagy 
may also be associated with the process of bone loss and 
subsequent osteoporosis.27,86
Recently, pharmacological inhibition with chloroquine 
and genetic inhibition by the selective deletion of the Atg7 
gene in monocytes have been shown to reduce osteoclas-
togenesis and decrease bone loss in animal models.74,87 
Administration of an antibody against sclerostin, an in-
hibitor of bone formation by osteoblasts, was able to pre-
vent bone loss promoted by treatment with glucocorticoids 
in male mice.88 In the study, treatment with high doses of 
glucocorticoids reduced the percentage of LC3-positive 
osteoblasts, an autophagic marker, thus reducing the vi-
ability of these cells and causing bone loss. Treatment with 
anti-sclerostin antibody, in turn, maintained the viability 
of osteoblasts by increasing autophagy in these cells and 
reducing bone loss caused by glucocorticoid treatment.88 
However, further studies are needed to understand the 
specific mechanisms by which sclerostin, or its antibody, 
regulates the autophagic pathway in bone cells.
Such findings indicate that autophagy contributes to 
the maintenance of bone mass, in part by maintaining the 
viability of osteoblasts. According to this idea, a deletion 
of the FIP200 gene (essential for autophagosome formation) 
in osteoblasts has been reported to cause osteopenia in rats 
due to the decrease in bone formation by these cells.89
In osteocytes, the deletion of the Atg7 gene (essential 
for autophagy initiation) has been shown to promote 
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bone mass decrease in 6-month-old male and female mice, 
similar to that caused by natural aging.86 In another study, 
a relationship was observed between decreased autopha-
gic activity in osteocytes and bone loss during aging in 
senile rat models.29 Recently, this result has also been 
achieved in senile rat models in which rapamycin, an 
autophagy inducer, reduced osteoporosis by activating 
autophagy in osteocytes.30
These studies indicate that the mechanism by which 
autophagy reduces the bone loss caused by aging in these 
models seems to be related to the antioxidant effect of 
autophagy on bone cells. The fact that oxidative stress was 
higher in knockout animal models for Atg7 reinforces this 
hypothesis.86 Also, although estrogen deficiency is consid-
ered a major cause of bone loss and osteoporosis in post-
menopausal women, studies have shown that increased 
oxidative stress in bone tissue is one of the major contrib-
uting factors to bone loss caused by aging.59,90,91 
In short, the reduction of autophagy appears to pro-
mote increased oxidative stress, causing bone loss, where-
as an increase in the autophagic pathway inhibits this 
effect.29,30,86 According to this hypothesis, a significant 
inverse correlation was observed between the level of au-
tophagy in osteocytes and the oxidative stress and bone 
loss caused by estrogen deficiency in the tibia of ovariec-
tomized rats.92  
Most evidence indicating a possible relationship be-
tween autophagic dysfunction and osteoporosis arises from 
studies in animal and in vitro models. In humans, how-
ever, there is still very little evidence to indicate such a re-
lationship. A genetic screening study in humans revealed 
that, among the different pathways studied, the expression 
of autophagic pathway regulatory genes was the only one 
that showed a direct relationship with the variation in bone 
mineral density in the distal portion of the radius in 984 
individuals.93 The authors concluded that this relationship 
may indicate an important participation of the autophagic 
pathway in the development of osteoporosis.
The preclinical in vivo and in vitro studies included 
in our review indicate a relationship between the dys-
regulation of the autophagic pathway and osteoporosis. 
This possible relationship is summarized in Figure 2.
FIGURE 2 Diagram illustrating the possible relationships between autophagy and osteoporosis. (A) Aging, prolonged treatment with 
glucocorticoids and estrogen deficiency increase oxidative stress in bone tissue, inducing apoptosis of osteoblasts and osteocytes and increased 
bone resorption by osteoclasts, which induces bone loss and osteoporosis. (B) On the other hand, increased oxidative stress stimulates the 
autophagic (+) pathway, which reduces the deleterious effect of stress by degrading damaged proteins and organelles. Reduction of cell stress 
inhibits the apoptosis of osteoblasts and osteocytes, decreasing bone loss and osteoporosis. A reduction of autophagy (-) caused by aging results 
in increased oxidative stress (C), which can cause bone loss and subsequent osteoporosis. Autophagy is also essential for the viability of 
osteoclasts. Thus, while the reduction of autophagy decreases the formation and resorptive activity of these cells (D), the increase of autophagy 
stimulates these processes (E). Arrows indicate stimulatory action and bars indicate inhibitory action.
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conclusion
In conclusion, based on experimental in vivo and in vitro 
studies, there is a number of evidences that reinforce the 
existence of a correlation between the autophagy process 
and osteoporosis. Nevertheless, future studies, especially 
clinical trials, are needed to confirm the possible relation-
ship between autophagic dysfunction and osteoporosis 
in humans, as well as to develop future therapies for the 
prevention and/or treatment of osteoporosis.
resuMo
Osteoporose e autofagia: qual é a relação?
A autofagia é uma via de sobrevivência celular pela qual 
proteínas e organelas não funcionais são degradadas nos 
lisossomos, para reciclagem e geração de energia. Assim, 
a autofagia é fundamental para a manutenção da homeos-
tase e viabilidade da célula, agindo como um controle de 
qualidade que evita o acúmulo de estruturas desnecessá-
rias e o estresse oxidativo. Um número crescente de estu-
dos tem demonstrado que disfunções na via autofágica 
estão relacionadas ao surgimento de diversas doenças, 
como as neurodegenerativas e o câncer. Estudos também 
têm indicado que a autofagia exerce um importante papel 
para a manutenção da homeostase óssea; por exemplo, 
estudos in vitro e em animais e humanos mostram que 
disfunções da autofagia nas células ósseas estão associa-
das ao surgimento de doenças ósseas, como a osteoporo-
se. Nesta revisão, foram abordados esses estudos, a fim 
de melhor esclarecer se há uma relação entre disfunção 
autofágica e osteoporose.
Palavras-chave: autofagia, tecido ósseo, osteoblasto, os-
teócito, osteoclasto, osteoporose.
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